The evolving epidemiology of acute coronary syndromes
暂无分享,去创建一个
[1] R. Mattu,et al. Impact of the recommendations for the redefinition of myocardial infarction on diagnosis and prognosis in an unselected United Kingdom cohort with suspected cardiac chest pain. , 2004, The American journal of cardiology.
[2] W. Rogers,et al. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.
[3] Philippe Amouyel,et al. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. , 1997 .
[4] D. Levy,et al. Temporal Trends in Coronary Heart Disease Mortality and Sudden Cardiac Death From 1950 to 1999: The Framingham Heart Study , 2004, Circulation.
[5] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[6] B. Yawn,et al. Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction , 2010, Circulation.
[7] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[8] T. Gaziano,et al. Cardiovascular Disease in the Developing World and Its Cost-Effective Management , 2005, Circulation.
[9] N Freemantle,et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.
[10] W. Markiewicz,et al. Appropriateness of diagnosis of unstable angina pectoris in patients referred for coronary arteriography. , 2008, Experimental and clinical cardiology.
[11] Sonia S. Anand,et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.
[12] E. Antman,et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. , 1996, Archives of internal medicine.
[13] C. Cannon,et al. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. , 2005, Journal of the American College of Cardiology.
[14] W. Gibler,et al. Racial Variations in Treatment and Outcomes of Black and White Patients With High-Risk Non–ST-Elevation Acute Coronary Syndromes: Insights From CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?) , 2005, Circulation.
[15] T. Thom,et al. Acute coronary syndrome national statistics: challenges in definitions. , 2005, American heart journal.
[16] J. Alpert,et al. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). , 2004, The American journal of cardiology.
[17] C. Husten,et al. Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.
[18] K. Kotseva,et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[19] C. Sempos,et al. Causes of declining life expectancy in Russia. , 1998, JAMA.
[20] K. Sliwa,et al. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study "Heart Awareness Days". , 2009, International journal of cardiology.
[21] Douglas L. Mann,et al. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th edition , 2018 .
[22] K. Thygesen,et al. Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .
[24] J. McMurray,et al. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. , 2006, The American journal of cardiology.
[25] A. Folsom,et al. Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996. , 2001, International journal of epidemiology.
[26] Yun Wang,et al. National impact of the troponin diagnostic standard on the prevalence and prognosis of acute myocardial infarction in older persons. , 2006, Critical pathways in cardiology.
[27] Elizabeth R DeLong,et al. ORIGINAL CONTRIBUTION Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes , 2022 .
[28] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[29] B. Gersh,et al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction , 2011 .
[30] Deepak L. Bhatt,et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.
[31] N. Powe,et al. Fourteen-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-elevation acute coronary syndromes in four United States communities. , 2005, The American journal of cardiology.
[32] Á. Avezum,et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). , 2005, American heart journal.
[33] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[34] Goutham Rao,et al. Childhood Obesity and Type 2 Diabetes Mellitus , 2005, Pediatrics.
[35] Ellen Meara,et al. Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage , 2009, Annals of Internal Medicine.
[36] J. Gore,et al. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. , 1999, Journal of the American College of Cardiology.
[37] K. Kotseva,et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.
[38] D R Jacobs,et al. Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997: The Minnesota Heart Survey , 2001, Circulation.
[39] A. Klimov,et al. Social factors and increase in mortality in Russia in the 1990s: prospective cohort study , 2003, BMJ : British Medical Journal.
[40] L. Wallentin,et al. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). , 2010, Archives of Internal Medicine.
[41] R. Pinner,et al. Trends in infectious disease mortality in the United States during the 20th century. , 1999, JAMA.
[42] Michael J Pencina,et al. Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction , 2008, Circulation.
[43] S. Yusuf,et al. Risk Factors Associated With Myocardial Infarction in Africa: The INTERHEART Africa Study , 2005, Circulation.
[44] S. Yusuf,et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. , 1994, Circulation.
[45] J. Alpert,et al. Universal definition of myocardial infarction. , 2007, European heart journal.
[46] R. Goldberg,et al. Recent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction. , 1999, American heart journal.
[47] J. Cutler,et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. , 2000, Circulation.
[48] Simon Capewell,et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.
[49] Shiva Gautam,et al. Daylight saving time shifts and incidence of acute myocardial infarction--Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). , 2012, Sleep medicine.
[50] D. Wood,et al. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001, The Lancet.
[51] S. Olshansky,et al. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. , 1986, The Milbank quarterly.
[52] J. Gore,et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). , 2002, The American journal of cardiology.
[53] V. Preedy,et al. Prospective Cohort Study , 2010 .
[54] P. Whincup,et al. How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study , 2008, Circulation.
[55] S. Normand,et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.
[56] L. Newby,et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/Ameri , 2005, Journal of the American College of Cardiology.
[57] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[58] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[59] A. Sabin. Control of Infectious Diseases , 1943, Nature.
[60] G. Filippatos,et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. , 2006, European heart journal.
[61] Deepak L. Bhatt,et al. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. , 2008, American heart journal.
[62] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.
[63] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[64] P. Basch. Quality of health care delivered to adults in the United States. , 2003, New England Journal of Medicine.
[65] H. Tunstall-Pedoe,et al. Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.
[66] J. Larosa,et al. Pleiotropic effects of statins and their clinical significance. , 2001, The American journal of cardiology.
[67] Douglas P. Zipes,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .
[68] R. D'Agostino,et al. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. , 1996, American journal of epidemiology.
[69] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[70] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[71] J. Alpert,et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .
[72] M. Richmond,et al. Distribution of R Plasmids Among the O-Antigen Types of Escherichia coli Isolated from Various Clinical Sources , 1976, Antimicrobial Agents and Chemotherapy.
[73] H. Tunstall-Pedoe,et al. Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases. , 1998, Annals of medicine.
[74] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[75] J. Tait,et al. Challenges and opportunities. , 1996, Journal of psychiatric and mental health nursing.
[76] Andy Wielgosz,et al. Socioeconomic status and cardiovascular disease: risks and implications for care , 2009, Nature Reviews Cardiology.
[77] J. Murabito,et al. Long-Term Trends in Myocardial Infarction Incidence and Case Fatality in the National Heart, Lung, and Blood Institute's Framingham Heart Study , 2009, Circulation.
[78] A. Go,et al. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. , 2010, Archives of internal medicine.
[79] Alan D. Lopez,et al. Global burden of disease and risk factors , 2006 .
[80] D. Wood. European Action on Secondary Prevention by Intervention to Reduce Events , 1998 .
[81] A. Folsom,et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.
[82] Salim Yusuf,et al. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. , 2010, European heart journal.
[83] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[84] P. Whelton,et al. Trends in blood pressure among children and adolescents. , 2004, JAMA.
[85] J. Ornato,et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.
[86] W. Osler. The Lumleian Lectures ON ANGINA PECTORIS. , 1910 .
[87] J. Gore,et al. Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study , 2004, Annals of Internal Medicine.
[88] M. Silverman. William heberden and some account of a disorder of the breast , 1987, Clinical cardiology.
[89] N. Sharpe,et al. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.
[90] B. Yawn,et al. Incidence of heart failure after myocardial infarction: is it changing over time? , 2003, American journal of epidemiology.
[91] S. L. Murphy,et al. Deaths: final data for 2003. , 2006, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.